Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare to Sell Fujifilm Imaging Systems

NEW YORK (GenomeWeb News) – General Electric unit GE Healthcare announced today that it has entered into a strategic alliance agreement with Fujifilm.

Under the agreement, Fujifilm will develop, manufacture, and supply biomolecular imaging systems to GE Healthcare, which will sell the products in life science and drug discovery markets around the world under the GE brand.

Fujifilm has developed a range of biomolecular imaging products over the years — from digital autoradiography devices to CCD camera systems. GE Healthcare, meanwhile, has introduced various non-radioactive biomolecular labeling and detection products.

In a statement today, Fujifilm Director and General Manager of the Life Science Products Division Yuzo Toda said that the agreement with GE Healthcare will combine Fujifilm's technology, R&D, and manufacturing with GE Healthcare's presence as a reagent and instrument supplier.

"By forming the alliance, both companies will make the most of our complementary capabilities to continue to the advancement of genomic and protein research," he said.

Nigel Darby, general manager of biotechnologies, life sciences at GE Healthcare, said that the FujiFilm products "fit well with our proprietary labeling technologies and the adjacent fields in the imaging workflow that GE Healthcare currently addresses."

Financial and other terms of the agreement were not disclosed.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.